BioClinica Partners With Health Sciences International and PRL Central Laboratory Services
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
“We are proud to partner with Health Sciences International and PRL Central Laboratory Services, expanding upon the dozens of CRO partnerships held by BioClinica worldwide,” said Mark Weinstein, CEO of BioClinica, Inc. “Our newest partners demonstrate the quality and continued growth of the BioClinica Certified Partner Program.
Connecticut-based Health Sciences International, Inc. focuses on conducting phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal medicine.
PRL Central Laboratory Services specializes in comprehensive diagnostic testing, focusing on protocol requirements.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
